Genmab | GEN - Pe Kurs-Gewinn

Aktienkurs
1,751.50
Täglich Wechseln
-7.00 -0.40%
Monatlich
1.54%
Jährlich
38.08%
Q2 Prognose
1,668.29




Pe Veränderung Datum
Agios Pharmaceuticals 3.56 0.68 2025-09
Almirall 79.43 0.3 2025-12
Amarin 91.05 88.3 2023-06
Amgen 25.31 15.82 2025-12
argenx SE 43.02 11.67 2025-12
AstraZeneca 27.29 5.8 2025-12
Bayer 5.93 0.68 2025-09
BioMarin Pharmaceutical 19.24 0.21 2025-12
Demant 27.46 7.1 2025-12
Exelixis 602.31 586.25 2025-12
Fresenius Medical Care 8.71 1.86 2025-12
Galapagos 3.14 50.78 2025-12
Genmab 17.14 4.39 2025-12
GlaxoSmithKline 11.15 0.29 2025-12
GN Store Nord 16.87 3.58 2025-09
GRIFOLS 16.81 28.19 2025-09
Hikma Pharmaceutical 10.43 3.72 2025-12
Lonza 34.34 2.58 2025-12
Merck 20.56 7.18 2025-12
Novartis 17.85 2.11 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Sanofi 11.99 1.58 2025-12
UCB 29.7 5.52 2025-12